Pay in 4 interest-free payments of $6.73 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
GLP-1 Receptor Agonist Market was valued at USD 44.5 Billion in 2023 and is projected to reach USD 95.4 Billion by 2031, growing at a CAGR of 10.3% during the forecast period 2024-2031
Medicare is also expanding access through the Medicare GLP-1 Bridge program, beginning July 1, 2026, for eligible Medicare Part D beneficiaries
M., Wei Y., Ginet V., Zhang L., Posner B., Tran K
Although patients with type 2 diabetes may eventually require insulin, interventions that enhance insulin sensitivity may be used to maintain normal blood glucose concentrations
US$ 24.34
US$ 25.79
US$ 28.15
US$ 28.38
US$ 21.08
US$ 24.48
US$ 27.78
